about
M2e-Based Universal Influenza A VaccinesDeveloping Universal Influenza Vaccines: Hitting the Nail, Not Just on the HeadTowards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensingAdvancements in the development of subunit influenza vaccinesIdentification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomainDevelopment of universal influenza vaccines based on influenza virus M and NP genes.MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 virusesUniversal influenza vaccines, a dream to be realized soon.Advances in influenza vaccination.Adenoviral vectors as novel vaccines for influenza.Synthesis and Immunogenicity Assessment of Elastin-Like Polypeptide-M2e Construct as an Influenza Antigen.Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.Animal models for the preclinical evaluation of candidate influenza vaccines.A universal long-term flu vaccine may not prevent severe epidemics.Universal vaccines: shifting to one for manyInfluenza A viruses: why focusing on M2e-based universal vaccines.Cross-protective immunity to influenza A viruses.Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin.Swine-origin influenza-virus-induced acute lung injury: Novel or classical pathogenesis?Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.Subviral particle as vaccine and vaccine platform.AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.Options and obstacles for designing a universal influenza vaccineVaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Cationic lipid/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunityImmunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.The potential economic value of a 'universal' (multi-year) influenza vaccineEpitope Mapping of Avian Influenza M2e Protein: Different Species Recognise Various Epitopes.Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.Subtype- and antigenic site-specific differences in biophysical influences on evolution of influenza virus hemagglutinin.Turning self-destructing Salmonella into a universal DNA vaccine delivery platform.An Influenza Virus M2 Protein Specific Chimeric Antigen Receptor Modulates Influenza A/WSN/33 H1N1 Infection In VivoPlant-derived virus-like particles as vaccinesTrivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.
P2860
Q26783493-FF50CDB7-96FA-4923-9505-C005FD9B06BAQ26783897-66296235-00BF-461B-9D2E-40A46A679F2BQ27003874-3247BFA7-1242-4D91-A1E3-F328A92B9E18Q27010100-7843709B-B6A2-42EB-9B6F-3FBCE0239E31Q27341132-A78CAF18-D359-41E9-BB0B-37C17B53EB06Q30355116-F002A9DC-FC58-4FA5-8300-D6CFCDF1A547Q30358935-269CAA0B-1628-4078-B750-F249E0BF38D4Q30361950-79C3A72C-5785-4AAB-B7B0-2299784252CDQ30364315-8D213CBD-96B0-4DB7-85D9-3F5718AF57EFQ30370445-2EBFD6E6-0CA6-45C7-B8F2-CDD181DC478DQ30373251-B54AC460-72B4-4BAA-8062-961028DCD039Q30373993-2FC8E283-6250-4002-8068-79207F081182Q30383623-D600CE86-89E1-423C-A497-8D572FAAD2EFQ30387700-4A91EB2A-7159-43FE-B7B3-54EAA25182EDQ30392373-B32F66CD-D1D9-4414-B2C9-9ED482169751Q30396318-B85C9137-E694-465C-9081-1E52FD8AF865Q30396399-2695DE98-911B-4FC3-88A3-767D682E4B71Q30401519-1263937A-8D40-4201-BC54-5730998A5FADQ30402300-1D7702F5-49BE-45ED-8E4F-DA36567B5E92Q30430152-E1BDEEE4-01DD-4771-B925-A9070E81C907Q33812653-51D22DEA-47C1-407C-B575-C8A8ED8AC4E0Q34019854-3F7729D5-F95D-427E-A09C-2986250FCFBFQ34059627-45A8A4C3-845B-4AE3-BF8A-6159A89A8D70Q34070683-FE96F4AE-9576-484E-AE46-504EC316E91FQ34102290-B2E47B11-3C25-4D12-91BA-B72E9B0B99C2Q34105207-CBC0155A-6749-43E1-B127-CF07BE0CCBF3Q34416393-56810AAF-13A2-48A5-9B9D-DAC0B9B56B14Q34430020-51622E1D-028A-4406-994E-E717277A1CC9Q35165017-531B9611-E941-46A1-A472-193059A1B752Q35209148-FF319225-185C-4E16-B95A-9EAA2F07EA91Q35645628-06804DA3-6352-4F0D-A9D6-B69AFAF58189Q35656657-9086277A-755A-42B4-B127-5E8CBC4319CEQ35661358-71A9F356-3911-46F3-A692-54413FB03F0DQ36065047-8C224AB7-13B6-451E-93B0-F1290747D791Q36267431-9F106768-3C49-4F8F-A7FB-4C7E16CAA152Q36402952-5F2E591A-FACA-49C3-BA84-5312B07586E9Q36436730-2005BD7F-B732-46EA-975E-C9647D01E258Q36675921-31E4FFB3-AE94-45CD-9C83-A607137EFDA9Q36888029-F88D7F0E-671D-4817-B61B-B8D5E483DE28Q36950550-4197F373-7C1A-4303-B7B3-F8CA0A37C274
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
M2e-based universal influenza A vaccine.
@ast
M2e-based universal influenza A vaccine.
@en
type
label
M2e-based universal influenza A vaccine.
@ast
M2e-based universal influenza A vaccine.
@en
prefLabel
M2e-based universal influenza A vaccine.
@ast
M2e-based universal influenza A vaccine.
@en
P2093
P1433
P1476
M2e-based universal influenza A vaccine.
@en
P2093
Ashley Birkett
Bert Schepens
Karim El Bakkouri
Kenny Roose
Marina De Filette
Michael Schotsaert
Walter Fiers
Xavier Saelens
P304
P356
10.1016/J.VACCINE.2009.07.007
P407
P577
2009-10-01T00:00:00Z